Filter
340
Text search:
mode
de
transmission
Featured
Recommendations
35
New Publications
77
Language
Document type
No document type
186
Guidelines
57
Studies & Reports
48
Manuals
26
Strategic & Response Plan
13
Training Material
4
Fact sheets
4
Situation Updates
2
Countries / Regions
Congo, Democratic Republic of
28
Senegal
15
Burkina Faso
9
Rwanda
9
Benin
9
Western and Central Europe
9
Global
9
Guinea
7
Côte d’Ivoire / Ivory Coast
7
Mali
6
Cameroon
6
Haiti
6
India
6
West and Central Africa
6
Sierra Leone
5
Ethiopia
5
Tanzania
5
Nigeria
4
Madagascar
4
Africa
4
Liberia
3
Malawi
3
South–East Asia Region
3
Eastern Europe
3
USA
2
Uganda
2
Niger
2
Togo
2
Philippines
2
Chad
2
South Africa
2
Bangladesh
2
Lesotho
2
Middle East and North Africa
2
Morocco
1
Somalia
1
Nepal
1
Pakistan
1
Iraq
1
Afghanistan
1
Germany
1
Zambia
1
Syria
1
Kenya
1
Central African Republic
1
Burundi
1
Ukraine
1
East and Southern Africa
1
Asia
1
Canada
1
Tajikistan
1
Estonia
1
Georgia
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
116
Clinical Guidelines
42
Key Resources
22
Women & Child Health
21
Public Health
10
Pharmacy & Technologies
5
Capacity Building
4
Toolboxes
HIV
41
COVID-19
35
Ebola & Marburg
30
TB
22
NTDs
20
Rapid Response
18
2.0 Rapid Response
10
Caregiver
9
AMR
8
Mental Health
6
Refugee
5
Zika
5
Planetary Health
5
Disability
4
Malaria
4
Pharmacy
3
Polio
2
Conflict
2
Natural Hazards
2
Specific Hazards
2
Cholera
1
Global Health Education
1
Social Ethics
1
Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326
March 2022. This report on good practices to combat AMR focuses on activities across human, animal, and environmental health in European countries. The report provides a description of practices, how they were implemented, achievements, and why the practice was unique.
This Guide contains information, guidelines, diagrams and other materials addressed to medical practitioners who are engaged in the treatment of casualties of chemical weapons. It is made available to the public for information purposes, but is not intended to be used by the public. All decisions re
...
The Open AIDS Journal, 2012, 6, 245-258
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
2nd edition. Training module on malaria control
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama
...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
HIV drug resistance strategies focus on prevention through adherence and treatment optimization, surveillance to monitor resistance trends, and innovation in new drugs and diagnostics. Key approaches include implementing national action plans, strengthening laboratory capacity for monitoring, and pr
...
From policy to practice: how the TB-HIV response is working
“The HIV community must place much more focus on TB co-infection than
it has done to date. TB takes the lives of over 1000 people living with HIV
every day, a number which is absolutely unacceptable. This report highlights that
TB d
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
